Developing new tools to sense biological signals for better health.
Center for Biomedical Research Excellence in Multiscale Biomolecular Sensing (MBS)
This study is working on new ways to spot and measure important biological signals in the body to help us better understand diseases like Alzheimer's and autoimmune disorders, with the hope of improving how we diagnose and treat patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11018373 on NIH RePORTER |
What this research studies
This research focuses on creating advanced tools to detect and measure biological signals that are crucial for understanding various diseases, including Alzheimer's and autoimmune disorders. By combining expertise from multiple scientific fields, the project aims to explore how biochemical processes occur at different scales, from molecules to entire organisms. The goal is to enhance our ability to sense these processes in real-time and in specific locations within the body, which could lead to improved diagnostics and treatments for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or other neurodegenerative disorders.
Not a fit: Patients with conditions unrelated to biochemical signaling or those who do not have neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in diagnosing and treating diseases like Alzheimer's and other neurodegenerative conditions.
How similar studies have performed: Other research has shown promising results in using advanced sensing technologies to improve understanding and treatment of complex diseases, indicating that this approach has potential for success.
Where this research is happening
Newark, UNITED STATES
- University of Delaware — Newark, United States (Active)
Researchers
- Principal investigator: Watson, Donald Allen — University of Delaware
- Study coordinator: Watson, Donald Allen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.